We used a biotin anti-EpCAM antibody and two different DNA templates, C1 and C2, to construct two kinds of antibody-DNA conjugates, allowing the two antibody-DNA conjugates to label the tumor exosomes. The gene discussed is EPCAM; the disease is neoplasm.